DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,554,027 | +3.9% | 90,907 | +0.5% | 2.89% | +9.8% |
| Q2 2023 | $21,705,840 | -4.5% | 90,441 | +0.3% | 2.64% | -8.0% |
| Q1 2023 | $22,720,650 | -5.0% | 90,147 | +0.0% | 2.87% | -7.5% |
| Q4 2022 | $23,920,447 | +3.2% | 90,123 | +0.4% | 3.10% | -0.4% |
| Q3 2022 | $23,174,000 | +7.1% | 89,722 | +5.1% | 3.11% | +17.1% |
| Q2 2022 | $21,634,000 | -13.4% | 85,333 | +0.1% | 2.66% | -1.5% |
| Q1 2022 | $24,995,000 | -10.2% | 85,211 | +0.7% | 2.70% | -5.6% |
| Q4 2021 | $27,841,000 | +9.0% | 84,621 | +0.8% | 2.86% | +5.3% |
| Q3 2021 | $25,549,000 | +13.8% | 83,922 | +0.3% | 2.71% | +10.3% |
| Q2 2021 | $22,451,000 | +19.4% | 83,659 | +0.2% | 2.46% | +12.4% |
| Q1 2021 | $18,797,000 | +2.8% | 83,512 | +1.5% | 2.19% | -4.2% |
| Q4 2020 | $18,283,000 | -10.2% | 82,305 | -12.9% | 2.28% | -10.5% |
| Q3 2020 | $20,355,000 | +21.8% | 94,531 | +0.0% | 2.55% | +15.3% |
| Q2 2020 | $16,712,000 | +27.9% | 94,510 | +0.1% | 2.21% | +8.3% |
| Q1 2020 | $13,068,000 | +16.3% | 94,416 | +29.0% | 2.04% | +51.1% |
| Q4 2019 | $11,236,000 | +26.2% | 73,208 | +13.6% | 1.35% | +3.4% |
| Q3 2019 | $8,906,000 | – | 64,429 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |